[Therapeutic effect of intraperitoneal administration of CDDP and OK-432 in peritonitis carcinomatosa cases in postoperative gastric carcinoma].
Tanaka
T
T
Dept. of Surgery, Osaka Hospital of West Japan, Railway Company.
Itoi
H
H
Matsui
S
S
Nakae
A
A
Nagashima
K
K
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D016131:Lymphocyte Subsets; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D010844:Picibanil / Q000008:administration & dosage; D011184:Postoperative Period; D011379:Prognosis; D013274:Stomach Neoplasms / Q000150:complications* / Q000601:surgery
D010844:Picibanil; D002945:Cisplatin